Current advances in humanized mouse models

Cellular and Molecular Immunology

Volumn 9, Issue 3, 2012, Pages 208-214

  Ito, Ryoji ^a   Takahashi, Takeshi ^a   Katano, Ikumi ^a   Ito, Mamoru ^a  

^a CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

Author keywords

animal model; hematology; humanized mice; immunodeficient mice; immunology

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; HLA A ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 21; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 7; RAG2 PROTEIN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; SIGNAL RECOGNITION PARTICLE;

ANIMAL CELL; BONE MARROW CELL; CONTROLLED STUDY; DENDRITIC CELL; ENGRAFTMENT; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION; LIVER; LYMPHOID CELL; MAST CELL; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUDE MOUSE; PHENOTYPE; REVIEW; SCID MOUSE; T LYMPHOCYTE; TISSUE DIFFERENTIATION; TISSUE TRANSPLANTATION;

ANIMALS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; HEMATOPOIESIS; HOMEODOMAIN PROTEINS; HUMANS; IMMUNE SYSTEM DISEASES; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; MUS;

EID: 84860876434     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2012.2     Document Type: Review

References (90)

1. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nat Rev Immunol 2007; 7: 118-130. (Pubitemid 46174859)
2. Ito M, Kobayashi K, Nakahata T. NOD/Shi-scid IL2rcnull (NOG) mice more appropriate for humanized mouse models. Curr Top Microbiol Immunol 2008; 324: 53-76.
3. Legrand N, Weijer K, Spits H. Experimental models to study development and function of the human immune system in vivo. J Immunol 2006; 176: 2053-2058. (Pubitemid 43201649)
4. Zhang B, Duan Z, Zhao Y. Mouse modelswith human immunity and their application in biomedical research. J Cell Mol Med 2009; 13: 1043-1058.
5. Issacson J, Cattanach B. Report. Mouse News Lett 1962; 27: 31.
6. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301: 527-530. (Pubitemid 13160576)
7. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180-191.
8. Koyanagi Y, Tanaka Y, Tanaka R, Misawa N, Kawano Y, Tanaka T et al. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection. Leukemia 11997; Suppl 3, 109-112.
9. Christianson SW, Greiner DL, Hesselton RA, Leif JH, Wagar EJ, Schweitzer IB et al. Enhanced human CD41 T cell engraftment in b2-microglobulin-deficient NOD-scid mice. J Immunol 1997; 158: 3578-3586. (Pubitemid 127488709)
10. Shultz LD, Banuelos S, Lyons B, Samuels R, Burzenski L, Gott B et al. NOD/LtSz- Rag1nullPfpnull mice: a new model system with increased levels of human peripheral leukocyte and hematopoietic stem-cell engraftment. Transplantation 2003; 76: 1036-1042. (Pubitemid 37280830)
11. Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K et al. NOD/SCID/ cc null mouse: an excellent recipient mouse model for engraftment of human cells. Blood 2002; 100: 3175-3182. (Pubitemid 35217065)
12. Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2Rcnull mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005; 174: 6477-6489. (Pubitemid 40663843)
13. Goldman JP, Blundell MP, Lopes L, Kinnon C, Di Santo JP, Thrasher AJ. Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor gamma chain. Br J Haematol 1998; 103: 335-342. (Pubitemid 28522436)
14. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004; 304: 104-107. (Pubitemid 38451466)
15. Pearson T, Shultz LD, Miller D, King M, Laning J, Fodor W et al. Non-obese diabeticrecombination activating gene-1 (NOD-Rag1null) interleukin (IL)-2 receptor common gamma chain (IL2rcnull) null mice: a radioresistant model for human lymphohaematopoietic engraftment. Clin Exp Immunol 2008; 154: 270-284.
16. Brehm MA, Cuthbert A, Yang C, Miller DM, DiIorio P, Laning J et al. Parameters for establishing humanized mouse models to study human immunity: analysis of human hematopoietic stem cell engraftment in three immunodeficient strains ofmice bearing the IL2rcnull mutation. Clin Immunol 2010; 135: 84-98.
17. Yahata T, Ando K, Nakamura Y, Ueyama Y, Shimamura K, Tamaoki N et al. Functional human T lymphocyte development from cord blood CD341 cells in nonobese diabetic/ Shi-scid, IL-2 receptor cnull mice. J Immunol 2002; 169: 204-209. (Pubitemid 34686137)
18. Hiramatsu H, NishikomoriR, Heike T, Ito M, Kobayashi K, Katamura K et al. Complete reconstitution of human lymphocytes from cord blood CD341 cells using the NOD/ SCID/ccnull mice model. Blood 2003; 102: 873-880. (Pubitemid 36917778)
19. Ishikawa F, Shimazu H, Shultz LD, Fukata M, Nakamura R, Lyons B et al. Purified human hematopoietic stem cells contribute to the generation of cardiomyocytes through cell fusion. FASEB J 2006; 20: 950-952.
20. Willinger T, Rongvaux A, Strowig T, Manz MG, Flavell RA. Improving human hematolymphoid- system mice by cytokine knock-in gene replacement. Trends Immunol 2011; 32: 321-327.
21. Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G et al. Development of functional human blood and immune systems in NOD/SCID/IL2 receptor c chainnull mice. Blood 2005; 106: 1565-1573. (Pubitemid 41208567)
22. Lepus CM, Gibson TF, Gerber SA, Kawikova I, Szczepanik M, Hossain J et al. Comparison of human fetal liver, umbilical cord blood, and adult blood hematopoietic stem cell engraftment in NOD-scid/cc2/2, Balb/c-Rag12/2cc2/2, and C.B-17-scid/bg immunodeficient mice. Hum Immunol 2009; 70: 790-802.
23. Matsumura T, Kametani Y, Ando K, Hirano Y, Katano I, Ito R et al. Functional CD51 B cells develop predominantly in the spleen of NOD/SCID/ccnull (NOG) mice transplanted either with human umbilical cord blood, bone marrow, or mobilized peripheral blood CD341 cells. Exp Hematol 2003; 31: 789-797. (Pubitemid 37075972)
24. Hayakawa J, Hsieh MM, Uchida N, Phang O, Tisdale JF. Busulfan produces efficient human cell engraftment in NOD/LtSz-Scid IL2Rcnull mice. Stem Cells 2009; 27: 175-182.
25. Watanabe Y, Takahashi T, Okajima A, Shiokawa M, Ishii N, Katano I et al. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/ccnull (NOG) mice (hu-HSC NOG mice). Int Immunol 2009; 21: 843-858.
26. McCune J, Kaneshima H, Krowka J, Namikawa R, Outzen H, Peault B et al. The SCIDhu mouse: a small animal model for HIV infection and pathogenesis. Annu Rev Immunol 1991; 9: 399-429.
27. McCune JM, Namikawa R, Kaneshima H, Shultz LD, Lieberman M, Weissman IL. The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science 1988; 241: 1632-1639.
28. Kirberg J, Berns A, von Boehmer H. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med 1997; 186: 1269-1275. (Pubitemid 27469022)
29. Custer RP, Bosma GC, Bosma MJ. Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms. Am J Pathol 1985; 120: 464-477. (Pubitemid 15250108)
30. Bosma MJ. B and T cell leakiness in the scid mouse mutant. Immunodefic Rev 1992; 3: 261-276. (Pubitemid 23003461)
31. Kato C, Fujii E, Chen YJ, Endaya BB, Matsubara K, Suzuki M et al. Spontaneous thymic lymphomas in the non-obese diabetic/Shi-scid, IL-2Rcnull mouse. Lab Anim 2009; 43: 402-404.
32. Katano I, Ito R, Eto T, Aiso S, Ito M. Immunodeficient NOD-scid IL-2Rcnull mice do not display T and B cell leakiness. Exp Anim 2011; 60: 181-186.
33. Sugamura K, Asao H, Kondo M, Tanaka N, Ishii N, Ohbo K et al. The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID. Annu Rev Immunol 1996; 14: 179-205. (Pubitemid 26130182)
34. Okada S, Harada H, Ito T, Saito T, Suzu S. Early development of human hematopoietic and acquired immune systems in new born NOD/Scid/Jak3null mice intrahepatic engrafted with cord blood-derived CD341 cells. Int J Hematol 2008; 88: 476-482.
35. Sato Y, Takata H, Kobayashi N, Nagata S, Nakagata N, Ueno T et al. Failure of effector function of human CD81 T cells in NOD/SCID/JAK3/ immunodeficientmice transplanted with human CD341 hematopoietic stem cells. PLoS One 2010; 5: e13109.
36. Miyakawa Y, Fukuchi Y, Ito M, Kobayashi K, Kuramochi T, Ikeda Y et al. Establishment of human granulocyte-macrophage colony stimulating factor produing transgenic SCID mice. Br J Haematol 1996; 95: 437-442. (Pubitemid 26388681)
37. Fukuchi Y, Miyakawa Y, Kobayashi K, Kuramochi T, Shimamura K, Tamaoki N et al. Cytokine dependent growth of human TF-1 leukemic cell line in human GM-CSF and IL-3 producing transgenic SCID mice. Leuk Res 1998; 22: 837-843. (Pubitemid 28388962)
38. Takenaka K, Prasolava TK, Wang JC, Mortin-Toth SM, Khalouei S, Gan OI et al. Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells. Nat Immunol 2007; 8: 1313-1323. (Pubitemid 350138972)
39. Takizawa H, Manz MG. Macrophage tolerance: CD47-SIRP-a-mediated signals matter. Nat Immunol 2007; 8: 1287-1289. (Pubitemid 350131166)
40. Rongvaux A, Willinger T, Takizawa H, Rathinam C, Auerbach W, Murphy AJ et al. Human thrombopoietin knockin mice efficiently support human hematopoiesis in vivo. Proc Natl Acad Sci USA 2011; 108: 2378-2383.
41. Willinger T, Rongvaux A, Takizawa H, Yancopoulos GD, Valenzuela DM, Murphy AJ et al. Human IL-3/GM-CSF knock-in mice support human alveolar macrophage development and human immune responses in the lung. Proc Natl Acad Sci USA 2011; 108: 2390-2395.
42. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rcnull humanized mice. Proc Natl Acad Sci USA 2010; 107: 13022-13027.
43. Danner R, Chaudhari SN, Rosenberger J, Surls J, Richie TL, Brumeanu TD et al. Expression of HLA class II molecules in humanized NOD.Rag1KO.IL2RgcKO mice is critical for development and function of human T and B cells. PLoS One 2011; 6: e19826.
44. Hiramatsu H, Nishikomori R, Heike T, Ito M, Kobayashi K, Katamura K et al. Complete reconstitution of human lymphocytes from cord blood CD341 cells using the NOD/ SCID/ccnull mice model. Blood 2003; 102: 873-880. (Pubitemid 36917778)
45. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H et al. T cell-mediated control of Epstein-Barr virus infection in humanized mice. J Infect Dis 2009; 200: 1611-1615.
46. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M et al. Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rcnull humanized mice. Proc Natl Acad Sci USA 2010; 107: 13022-13027.
47. Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J et al. Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med 2009; 206: 1423-1434.
48. Suwanai H, Wilcox MA, Mathis D, Benoist C. A defective Il15 allele underlies the deficiency in natural killer cell activity in nonobese diabetic mice. Proc Natl Acad Sci USA 01;107: 9305-9310.
49. Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A et al. IL-15 transpresentation promotes human NK cell development and differentiation in vivo. J Exp Med 2009; 206: 25-34.
50. Chen Q, Khoury M, Chen J. Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci USA 2009; 106: 21783-21788.
51. Shiokawa M, Takahashi T, Murakami A, Kita S, Ito M, SugamuraKet al. In vivo assay of human NK-dependent ADCC using NOD/SCID/ccnull (NOG) mice. Biochem Biophys Res Commun 2010; 399: 733-737.
52. Billerbeck E, Barry WT, Mu K, Dorner M, Rice CM, Ploss A. Development of human CD41FoxP31 regulatory T cells in human stem cell factor-, granulocytenmacrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2Rcnull humanized mice. Blood 2011; 117: 3076-3086.
53. Williams CM, Galli SJ. The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 2000; 105: 847-859. (Pubitemid 30324391)
54. Galli SJ, Wershil BK. The two faces of the mast cell. Nature 1996; 381: 21-22. (Pubitemid 26129994)
55. Kambe N, Hiramatsu H, Shimonaka M, Fujino H, Nishikomori R, Heike T et al. Development of both human connective tissue-type and mucosal-type mast cells in mice from hematopoietic stem cells with identical distribution pattern to human body. Blood 2004; 103: 860-867. (Pubitemid 38129543)
56. Machida K, Suemizu H, Kawai K, Ishikawa T, Sawada R, Ohnishi Y et al. Higher susceptibility of NOG mice to xenotransplanted tumors. J Toxicol Sci 2009; 34: 123-127.
57. Suemizu H, Monnai M, Ohnishi Y, Ito M, Tamaoki N, Nakamura M. Identification of a key molecular regulator of liver metastasis in human pancreatic carcinoma using a novel quantitative model of metastasis in NOD/SCID/ccnull (NOG) mice. Int J Oncol 2007; 31: 741-751.
58. Miyakawa Y, Ohnishi Y, Tomisawa M, Monnai M, Kohmura K, Ueyama Y et al. Establishment of a new model of human multiple myeloma using NOD/SCID/ccnull (NOG) mice. Biochem Biophys Res Commun 2004; 313: 258-262. (Pubitemid 37543579)
59. Ninomiya M, Kiyoi H, Ito M, Hirose Y, Naoe T. Retinoic acid syndrome in NOD/scid mice induced by injecting an acute promyelocytic leukemia cell line. Leukemia 2004; 18: 442-448. (Pubitemid 38425857)
60. Ito R, Katano I, Kawai K, Hirata H, Ogura T, Kamisako T et al. Highly sensitive model for xenogenic GVHD using severe immunodeficient NOG mice. Transplantation 2009; 87: 1654-1658.
61. Zhang L, Meissner E, Chen J, Su L. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis. Sci China Life Sci 2010; 53: 195-203.
62. Namikawa R, Kaneshima H, Lieberman M, Weissman IL, McCune JM. Infection of the SCID-hu mouse by HIV-1. Science 1988; 242: 1684-1686. (Pubitemid 19022172)
63. Mosier DE, Gulizia RJ, Baird SM, Wilson DB. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature 1988; 335: 256-259.
64. Koyanagi Y, Tanaka Y, Ito M, Yamamoto N. Humanized mice for human retrovirus infection. Curr Top Microbiol Immunol 2008; 324: 133-148.
65. Sato K, Nie C, Misawa N, Tanaka Y, Ito M, Koyanagi Y. Dynamics of memory and naive CD81 T lymphocytes in humanized NOD/SCID/IL-2Rcnull mice infected with CCR5- tropic HIV-1. Vaccine 82010; Suppl 2, B32-37.
66. Watanabe S, Ohta S, Yajima M, Terashima K, Ito M, Mugishima H et al. Humanized NOD/SCID/IL2Rcnull mice transplanted with hematopoietic stem cells under nonmyeloablative conditions show prolonged life spans and allow detailed analysis of human immunodeficiency virus type 1 pathogenesis. J Virol 2007; 81: 13259-13264. (Pubitemid 350156965)
67. Watanabe S, Terashima K, Ohta S, Horibata S, Yajima M, Shiozawa Y et al. Hematopoietic stem cell-engrafted NOD/SCID/IL2Rcnull mice develop human lymphoid systems and induce long-lasting HIV-1 infection with specific humoral immune responses. Blood 2007; 109: 212-218. (Pubitemid 46070123)
68. Denton PW, Estes JD, Sun Z, Othieno FA, Wei BL, Wege AK et al. Antiretroviral preexposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice. PLoS Med 2008; 5: e16.
69. Olesen R, Wahl A, Denton PW, Garcia JV. Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection. J Reprod Immunol 2011; 88: 195-203.
70. Choudhary S, Archin N, Cheema M, Dahl N, Garcia JV, Margolis D. Latent HIV-1 infection of resting CD41 T cells in the humanized Rag22/2cc2/2 mouse. J Virol 2012; 86: 114-120.
71. Rickinson AB, Kieff E. Epstein-Barr virus. In:Knipe DM, Howley PM (eds.) Fields virology. Philadelphia: Lippincott Williams & Wilkins, 2011: 2575-2628.
72. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H et al. A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J Infect Dis 2008; 198: 673-682.
73. Sato K,Misawa N, Nie C, Satou Y, Iwakiri D, MatsuokaMet al. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice. Blood 2011; 117: 5663-5673.
74. Imadome K, Yajima M, Arai A, Nakazawa A, Kawano F, Ichikawa S et al. Novel mouse xenograft models reveal a critical role of CD41 T cells in the proliferation of EBVinfected T and NK cells. PLoS Pathog 2011; 7: e1002326.
75. Song J, Willinger T, Rongvaux A, Eynon EE, Stevens S, Manz MG et al. A mouse model for the human pathogen Salmonella typhi. Cell Host Microbe 2010; 8: 369-376.
76. Libby SJ, Brehm MA, Greiner DL, Shultz LD, McClelland M, Smith KD et al. Humanized nonobese diabetic-scid IL2rcnull mice are susceptible to lethal Salmonella typhi infection. Proc Natl Acad Sci USA 2010; 107: 15589-15594.
77. FirozMianM, Pek EA, ChenowethMJ, Ashkar AA. Humanizedmice are susceptible to Salmonella typhi infection. Cell Mol Immunol 2011; 8: 83-87.
78. Sauerwein RW, Roestenberg M, Moorthy VS. Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol 2011; 11: 57-64.
79. Azuma H, Paulk N, Ranade A, Dorrell C, Al-DhalimyM, Ellis E et al. Robust expansion of human hepatocytes in Fah2/2/Rag22/2/Il2rg2/2 mice. Nat Biotechnol 2007; 25: 903-910. (Pubitemid 47236918)
80. Hasegawa M, Kawai K, Mitsui T, Taniguchi K, Monnai M, Wakui M et al. The reconstituted 'humanized liver' in TK-NOG mice is mature and functional. Biochem Biophys Res Commun 2011; 405: 405-410.
81. Mercer DF, Schiller DE, Elliott JF, Douglas DN, Hao C, Rinfret A et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med 2001; 7: 927-933. (Pubitemid 32756430)
82. Suemizu H, Hasegawa M, Kawai K, Taniguchi K, Monnai M, Wakui M et al. Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice. Biochem Biophys Res Commun 2008; 377: 248-252.
83. Mikolajczak SA, Sacci JB Jr, de la Vega P, Camargo N, VanBuskirk K, Krzych U et al. Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites. Cell Microbiol 2011; 13: 1250-1260.
84. Jimenez-Diaz MB, Mulet T, Viera S, Gomez V, Garuti H, Ibanez J et al. Improved murine model of malaria using Plasmodium falciparum competent strains and nonmyelodepleted NOD-scid IL2Rcnull mice engrafted with human erythrocytes. Antimicrob Agents Chemother 2009; 53: 4533-4536.
85. Bissig KD, Wieland SF, Tran P, Isogawa M, Le TT, Chisari FV et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J Clin Invest 2010; 120: 924-930.
86. Haridass D, Yuan Q, Becker PD, Cantz T, Iken M, Rothe M et al. Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol 2009; 175: 1483-1492.
87. Washburn ML, Bility MT, Zhang L, Kovalev GI, Buntzman A, Frelinger JA et al. A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease. Gastroenterology 2011; 140: 1334-1344.
88. Martino G, Anastasi J, Feng J, Mc Shan C, DeGroot L, Quintans J et al. The fate of human peripheral blood lymphocytes after transplantation into SCID mice. Eur J Immunol 1993; 23: 1023-1028. (Pubitemid 23120160)
89. van Rijn RS, Simonetti ER, Hagenbeek A, Hogenes MC, de Weger RA, Canninga-van Dijk MR et al. A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG22/2 cc2/2 doublemutant mice. Blood 2003; 102: 2522-2531. (Pubitemid 37193591)
90. King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J et al. Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin- 2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 2009; 157: 104-118.